Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar-Apr;27(2):102743.
doi: 10.1016/j.bjid.2023.102743. Epub 2023 Jan 31.

Epoxy-α-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2H-naphtho[2,3-b]pyran-10,2'-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites

Affiliations
Review

Epoxy-α-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2H-naphtho[2,3-b]pyran-10,2'-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites

Juliana Figueiredo Peixoto et al. Braz J Infect Dis. 2023 Mar-Apr.

Abstract

Natural products and their derivatives have been sources of search and research for new drugs for the treatment of neglected diseases. Naphthoquinones, a special group of quinones, are products of natural metabolites with a wide spectrum of biological activities and represent a group of interesting molecules for new therapeutic propositions. Among these compounds, lapachol stands out as a molecule from the heartwood of Tabebuia sp. whose structural changes resulted in compounds considered promising, such as epoxy-α-lapachone (ELAP). The biological activity of ELAP has been demonstrated, so far, for parasitic protozoa such as Leishmania spp., Trypanosoma cruzi and Plasmodium spp., species causing diseases needing new drug development and adequate health policy. This work gathers in vitro and in vivo studies on these parasites, as well as the toxicity profile, and the probable mechanisms of action elucidated until then. The potential of ELAP-based technology alternatives for a further drug is discussed here.

Keywords: Chagas disease; Epoxy-α-lapachone; Leishmaniasis; Malaria; Naphthoquinone; Treatment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest The authors declare no conflicts of interest.

Figures

Fig 1
Fig. 1
Naphthoquinone anti-parasitic activity plot based on experimental assays. The compounds α-lapachone (A), β-lapachone (B), 2,2-dimethylspiro[3H-benzo[f][1]benzofuran-9,2′-oxirane]-4-one (C), 2,2-dimethylspiro[3,4,6,7,8,9-hexahydrobenzo[g]chromene-10,2′-oxirane]-5-one (D), 2,2-dimethylspiro[3,4-dihydrobenzo[h]chromene-6,2′-oxirane]-5-one (E) and epoxy-α -lapachone (F) were selected according to structural similarity (>50%) using the ChEMBL Database (https://www.ebi.ac.uk/chembl/). This analysis shows the activities of these molecules against to Plasmodium spp. (purple circle), Trypanosoma cruzi (yellow circle), and Leishmania spp. (green circle) based on IC50 values normalized (pChEMBL value). The circle sizes show a predict values of permeability (ALogP) of these compounds.
Fig 2
Fig. 2
Predicted epoxy-α-lapachone regions interactions with amino acid residues of the active site of trypanosomatid proteases. Epoxy-α-lapachone (2,3-Dihydro-3,3-dimethylspiro[1H-4-oxanthracene-5,2′-oxiran]−10(5H)-one) is formed by an aromatic ring (A), a central six-membered ring (B) and a ring with two methyl groups (C). The chiral center being the C12 atom, which is also part of the three-membered epoxide ring. CID: 12,000,280; molecular formula:C16H16O3 and molecular mass: 256.3 g/mol. Epoxy-α-lapachone regions interactions with amino acid residues of cysteine-proteinase (green) of Trypanosoma cruzi and serine-proteinase (orange) of Leishmania (Leishmania) amazonensis.

References

    1. https://www.who.int/health-topics/neglected-tropical-diseases#tab=tab_1 (accessed 09.16.22).
    1. https://apps.who.int/iris/bitstream/handle/10665/311689/9789241515450-en... (acessed 09.16.22).
    1. https://apps.who.int/iris/handle/10665/255011 (accessed 09.16.22).
    1. https://apps.who.int/iris/handle/10665/152781 (accessed 09.16.22)
    1. Ferreira L.L.G., Andricopulo A.D. Drugs and vaccines in the 21st century for neglected diseases. Lancet Infect Dis. 2019;1:125–127. - PubMed